Rashmi Choudhary is a highly experienced professional in the field of biochemistry and translational medicine, with a comprehensive background in cell therapies and immunology. Currently serving as a Translational Strategy Leader for Cell Therapies at Takeda Oncology, Rashmi has previously held positions as a Senior Scientist at both Takeda Pharmaceuticals America, Inc. and AgenTus Therapeutics, as well as Scientist roles focused on immunology at TCR2, Inc. Rashmi's academic foundation includes a PhD in Biochemistry obtained from Osmania University between 1999 and 2006, along with research experience as a faculty member and postdoctoral fellow at Johns Hopkins University.